Neil M Nathanson Selected Research

Muscarinic Agonists

2/2015	Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon-induced seizures.
1/2014	Modulation of pilocarpine-induced seizures by cannabinoid receptor 1.
4/2003	Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil M Nathanson Research Topics

Disease

4	Seizures (Absence Seizure) 02/2015 - 04/2003
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Endotoxemia 01/2019
1	Myopia 01/2018
1	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 11/2014
1	Epilepsy (Aura) 01/2014
1	Noise-Induced Hearing Loss (Acoustic Trauma) 05/2010
1	Ototoxicity 03/2009
1	Leukemia 08/2008
1	Neuroblastoma 08/2008
1	Choriocarcinoma 03/2008
1	Parkinson Disease (Parkinson's Disease) 11/2007
1	Overactive Urinary Bladder (Overactive Bladder) 07/2006
1	Tremor (Tremors) 04/2003
1	Hypothermia 04/2003
1	Cognitive Dysfunction 01/2003
1	Atrioventricular Block 04/2002
1	Atrial Fibrillation 04/2002
1	Cardiac Arrhythmias (Arrythmia) 04/2002

Drug/Important Bio-Agent (IBA)

7	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019 - 04/2003
4	Pilocarpine (Ocusert)FDA LinkGeneric 02/2015 - 04/2003
3	Cholinergic Agents (Cholinergics)IBA 01/2019 - 04/2003
3	Muscarinic AntagonistsIBA 01/2018 - 07/2006
3	Muscarinic M1 ReceptorIBA 02/2015 - 01/2003
3	Muscarinic AgonistsIBA 02/2015 - 04/2003
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 01/2003
2	CannabinoidsIBA 02/2015 - 01/2014
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2015 - 01/2014
2	CytokinesIBA 03/2009 - 08/2008
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2019
1	Carboxylic AcidsIBA 01/2019
1	QuinolonesIBA 01/2019
1	Atropine FDA LinkGeneric 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	LigandsIBA 01/2018
1	OrganophosphatesIBA 02/2015
1	Paraoxon (E600)IBA 02/2015
1	OSM-LIF ReceptorsIBA 11/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2014
1	EndocannabinoidsIBA 01/2014
1	AutoreceptorsIBA 05/2010
1	MicroRNAs (MicroRNA)IBA 04/2010
1	Cisplatin (Platino)FDA LinkGeneric 03/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2008
1	Mitogen-Activated Protein KinasesIBA 08/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2008
1	Monomeric GTP-Binding ProteinsIBA 03/2008
1	Dopamine (Intropin)FDA LinkGeneric 11/2007
1	ParasympathomimeticsIBA 04/2003
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2003
1	OxotremorineIBA 04/2003
1	CatecholaminesIBA 04/2002

Therapy/Procedure

1	Vagotomy 01/2019
1	Intravenous Injections 04/2002